Misagh Mohammadi

Misagh Mohammadi

Auto-generated profile, based on publicly available information

Misagh Mohammadi

Department of Analytical Chemistry and Pollutants, Shahid Beheshti University, Tehran, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 September 2024 in Discover Nano
Verified
Journal Article
Open access
PDF file
MMMisagh Mohammadi
Misagh Mohammadi
MKMehrnaz Karimi
Mehrnaz Karimi
FRFarhad Raofie
Farhad Raofie
A semi-synthetic camptothecin derivative known as irinotecan hydrochloride is frequently used to treat colorectal cancer, including colorectal adenocarcino

2 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMisagh Mohammadi
Misagh Mohammadi
MKMehrnaz Karimi
Mehrnaz Karimi
FRFarhad Raofie
Farhad Raofie
Sertraline is one of the drugs whose transport from the blood circulation to the brain is severely limited by the blood–brain barrier and it shows low bioavailability (44%). Liposomes can be an effective carrier for this drug and increase bioavailability. In this study, the synthesis of nanometer-sized liposomes containing sertraline hydrochloride is proposed using a technique called supercritical fluid expansion into aqueous solution (ESSAS). In this technique, phospholipid precipitation rates are controlled, and homogeneous liposomes with nanometer-sized dimensions can be created. The operational parameters were optimized using the response surface methodology (pressure drop: 29.9 MPa, collection time: 13.6 min, temperature: 40 °C), which showed that the optimal values for the encapsulation efficiency, mean size, and number of liposomes were 78.4%, 89.5 nm, and 85, respectively. Also, the drug release test showed that it takes 27 h for sertraline to be completely released from the liposomal suspension.